CBX4 and hepatocellular carcinoma: More intriguingly, we showed that Cbx4 overexpression significantly enhanced, while Cbx4 silencing antagonized, doxorubicin-induced death of HCC cells, supporting the notion that Cbx4 increases the sensitivity of HCC cells to doxorubicin in TACE treatment.